Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Immunotherapy is the newest class of medications used to fight cancer and is being used with increasing frequency across a wide array of cancers including lymphoma, melanoma, non-small cell lung cancer, bladder and kidney cancer, and some head and neck cancers. Immunotherapies are being studied as potential treatments in a number of other cancers.
Immunotherapy often works more effectively in combination with other drug therapies like chemotherapy.
Our program finds new ways to harness the immune system to fight cancer. Our physician scientists develop innovative treatments and deliver mechanisms to provide durable, robust cancer immune responses.